Inhibitors of nonenzymatic cross-linking

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514614, 424400, 424401, 426268, 426269, 426320, 426321, A01N 4106, A01N 4112, A61K 900, A23L 127

Patent

active

051400480

ABSTRACT:
The present invention relates to compositions and methods for inhibiting nonenzymatic cross-linking (protein aging). Accordingly, a composition is disclosed which comprises; an agent capable of inhibiting the formation of advanced glycosylation endproducts of target proteins by reacting with the carbonyl moiety of the early glycosylation product of such target proteins formed by their initial glycosylation. Suitable agents contain an active nitrogen-containing group, such as a hydrazine group. Particular agents comprise aminoguanidine derivatives. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated.

REFERENCES:
patent: 3053732 (1962-09-01), Greenhalgh
patent: 3055882 (1962-09-01), Mull
patent: 3055883 (1962-09-01), Mull
patent: 3098066 (1963-07-01), Mull
patent: 3101336 (1963-08-01), James et al.
patent: 3178433 (1965-04-01), Mull
patent: 3506680 (1970-04-01), Berger et al.
patent: 3681504 (1972-08-01), Johnston et al.
patent: 3978060 (1976-08-01), Forsyth et al.
patent: 3980774 (1976-09-01), Hegarty et al.
patent: 3991209 (1976-11-01), Forsyth et al.
patent: 4544759 (1985-10-01), Hlavka et al.
patent: 4665192 (1987-05-01), Cerami
patent: 4758583 (1988-07-01), Cerami et al.
Bunn, H. F. et al. Further identification of the nature & linkage of the carbohydrate in hemoglobin A.sub.1c, Biochem. & Biophys. Res. Comm., 67(1), 1975, 103-109.
Brownlee, M. et al., Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking, Science, 232, 1986, 1629-1632.
Brownlee, M. et al. Nonenzymatic glycosylation & the pathogenesis of diabetic complications, Ann. Int. Med., 101, 1984, 527-537.
Brownlee, M. et al. Covalent attachment of soluble proteins by nonenzymatic glycosylated collage, J. Exp. Med., 158, 1983, 1739-1744.
Eble, A. s. et al. Nonenzymatic glucosylation & glucose-dependent cross-linking of protein, J. Biol. Chem., 238, 1983, 9406-9412.
Godfrey, L. E. A. The synthesis of heterocyclic compounds from urea derivatives, Doctoral dissertation, U. of London, 1962.
Hollis, et al., Diabetologia, 28, 1985, 282-285.
Koenig et al., J. Biol. Chem., 252, 1977, 2992-2997.
Kohn et al., Diabetes, 33, 1984, 57-59.
Lindberg et al., Acta Obst. Gynecol. Scandinav., 45, 1966, 131-139.
Maillard, C. R., Acad. Sci., 154, 1912, 66-68.
Monnier et al., Proc. Natl. Acad. Sci., USA, 81, 1984, 583-587.
Monnier et al., Amer. Chem. Soc., 215, 1983, 431-448.
Monnier et al., Clinics in Endocrinology and Metabolism, 11, 1982, 431-452.
Monnier et al., Science, 211, 1981, 491-493.
Monnier et al., Biochem. Biophys. Acta, 760, 1983, 77-103.
Stoner, Agents and Actions, 17, 1985, 5-9.
Tai et al., J. Med. Chem., 27, 1984, 236-238.
Ebetino et al., J. Org. Chem., 27, 188-191 (1962).
Ebetino, J. Org. Chem., 29, 2582-2585 (1964).
Eble et al., J. Bio. Chem., 258, 9406-9412 (1983).
Sundberg et al., J. Med. Chem., 33, 298 (1990).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Inhibitors of nonenzymatic cross-linking does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of nonenzymatic cross-linking, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of nonenzymatic cross-linking will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1249357

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.